Search Browse Earnings

HCW Biologics Inc. — SlamSEC

HCW Biologics Inc.

Nasdaq:HCWB

Pharmaceutical Preparations·MIRAMAR, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$4.1M

FY 2021

Adj. EBITDA

-$24.6M

-599.6% margin

FY 2024

Net Income

-$25.0M

-609.7% margin

FY 2024

EPS (Diluted)

-$0.70

FY 2024

Stock Price

$0.56

-5.5%

2026-03-10

52W Range

$0.49 – $17.80

P/E Ratio

-0.8x

Market Cap

$1.5M

Cash

$3.6M

FY 2024

Total Debt

$6.3M

FY 2024

Net Debt

$2.7M

FY 2024

Enterprise Value

$4.2M

Debt / EBITDA

-0.1x

FY 2021

EV / EBITDA

-0.2x

Employees

—